Stand no: 11G58
Macfarlan Smith, a Johnson Matthey PLC business, is a world leader in the production of alkaloid opiates and other controlled drugs. As one of the world's oldest pharmaceutical companies, Macfarlan Smith has manufactured and developed both active pharmaceutical ingredients and intermediates for more than 200 years, and today the company operates a state-of-the-art plant to the highest level of cGMP. Natural product extraction is another area of expertise with our extraction facilities being fully integrated with our other API manufacturing units, allowing for the provision of commercially viable alternatives to synthetic routes.
As part of the Johnson Matthey Fine Chemicals & Catalysts Division, with operations in Europe and North America, we bring together a number of world class business units offering a fully integrated drug development and production service, operated to the highest standards.
Macfarlan Smith offers a comprehensive contract manufacturing facility ranging from the development of novel synthetic processes, through lab-scale production to the provision of multi-tonne custom synthesis, which includes the toll extraction of active principals from natural products.
Our facilities are both MHRA and FDA approved.